Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Embryonal Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Embryonal Neoplasm

Cancer Family

Embryonal Neoplasm

CI-CAN-00000013Explore in graph →

Non-malignant285 active trials7 approved drugs73 evidence items

NCIt: C3264
OncoTree: EMBT
UMLS CUI: C0027654

Overview
Statistics
Survival
Genomics22
Variants & evidence73
Drugs28
Trials1126
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (70)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 70 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.
· Cancer Cell · 2009 · PMID 19962671 · validated civic_curation pubmed
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.
· Nat Genet · 2014 · PMID 24316981 · validated civic_curation pubmed
The molecular landscape of ETMR at diagnosis and relapse.
· Nature · 2019 · PMID 31802000 · validated civic_curation pubmed
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
· Cancer Cell · 2014 · PMID 25517749 · validated civic_curation pubmed
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
· Cancer Discov · 2017 · PMID 28183697 · validated civic_curation pubmed
Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
· Hum Pathol · 2013 · PMID 23706910 · validated civic_curation pubmed
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
· Lancet Oncol · 2017 · PMID 28545823 · validated civic_curation

Showing 1–25 of 70 publications

← Previous
1
2
3
Next →

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

· J Clin Oncol · 1998 · PMID 9552022 · validated civic_curation pubmed

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

· Cancer Cell · 2014 · PMID 24651015 · validated civic_curation pubmed

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

· Lancet Oncol · 2013 · PMID 23598171 · validated civic_curation pubmed

The genomic landscape of pediatric Ewing sarcoma.

· Cancer Discov · 2014 · PMID 25186949 · validated civic_curation pubmed

Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).

· Cancer Genet Cytogenet · 1988 · PMID 3163261 · validated civic_curation pubmed

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

· N Engl J Med · 1993 · PMID 8441429 · validated civic_curation pubmed

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

· Cell Cycle · 2006 · PMID 17172831 · validated civic_curation pubmed

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

· Cell · 2016 · PMID 26919435 · validated civic_curation pubmed

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

· Am J Surg Pathol · 2004 · PMID 15105654 · validated civic_curation pubmed

Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.

· Acta Neuropathol Commun · 2021 · PMID 33536079 · validated civic_curation pubmed

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

· Neuro Oncol · 2022 · PMID 35395680 · validated civic_curation pubmed

Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.

· Clin Epigenetics · 2023 · PMID 36895035 · validated civic_curation pubmed

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.

· PLoS One · 2014 · PMID 25502557 · validated civic_curation pubmed

Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors.

· Mod Pathol · 2006 · PMID 16258512 · validated civic_curation pubmed

Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.

· J Pathol · 2009 · PMID 19197950 · validated civic_curation pubmed

Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.

· Iran J Kidney Dis · 2011 · PMID 21525573 · validated civic_curation pubmed

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.

· Mod Pathol · 2013 · PMID 23060122 · validated civic_curation pubmed

Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

· Br J Cancer · 1994 · PMID 7524604 · validated civic_curation pubmed